Evaluating artificial intelligence software for delineating hemorrhage extent on CT brain imaging in stroke: AI delineation of ICH on CT.

Artificial intelligence CT Hemorrhage Stroke

Journal

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633

Informations de publication

Date de publication:
25 Nov 2023
Historique:
received: 07 06 2023
revised: 25 10 2023
accepted: 21 11 2023
medline: 27 11 2023
pubmed: 27 11 2023
entrez: 26 11 2023
Statut: aheadofprint

Résumé

The extent and distribution of intracranial hemorrhage (ICH) directly affects clinical management. Artificial intelligence (AI) software can detect and may delineate ICH extent on brain CT. We evaluated e-ASPECTS software (Brainomix Ltd.) performance for ICH delineation. We qualitatively assessed software delineation of ICH on CT using patients from six stroke trials. We assessed hemorrhage delineation in five compartments: lobar, deep, posterior fossa, intraventricular, extra-axial. We categorized delineation as excellent, good, moderate, or poor. We assessed quality of software delineation with number of affected compartments in univariate analysis (Kruskall-Wallis test) and ICH location using logistic regression (dependent variable: dichotomous delineation categories 'excellent-good' versus 'moderate-poor'), and report odds ratios (OR) and 95 % confidence intervals (95 %CI). From 651 patients with ICH (median age 75 years, 53 % male), we included 628 with assessable CTs. Software delineation of ICH extent was 'excellent' in 189/628 (30 %), 'good' in 255/628 (41 %), 'moderate' in 127/628 (20 %), and 'poor' in 57/628 cases (9 %). The quality of software delineation of ICH was better when fewer compartments were affected (Z = 3.61-6.27; p = 0.0063). Software delineation of ICH extent was more likely to be 'excellent-good' quality when lobar alone (OR = 1.56, 95 %CI = 0.97-2.53) but 'moderate-poor' with any intraventricular (OR = 0.56, 95 %CI = 0.39-0.81, p = 0.002) or any extra-axial (OR = 0.41, 95 %CI = 0.27-0.62, p<0.001) extension. Delineation of ICH extent on stroke CT scans by AI software was excellent or good in 71 % of cases but was more likely to over- or under-estimate extent when ICH was either more extensive, intraventricular, or extra-axial.

Sections du résumé

BACKGROUND BACKGROUND
The extent and distribution of intracranial hemorrhage (ICH) directly affects clinical management. Artificial intelligence (AI) software can detect and may delineate ICH extent on brain CT. We evaluated e-ASPECTS software (Brainomix Ltd.) performance for ICH delineation.
METHODS METHODS
We qualitatively assessed software delineation of ICH on CT using patients from six stroke trials. We assessed hemorrhage delineation in five compartments: lobar, deep, posterior fossa, intraventricular, extra-axial. We categorized delineation as excellent, good, moderate, or poor. We assessed quality of software delineation with number of affected compartments in univariate analysis (Kruskall-Wallis test) and ICH location using logistic regression (dependent variable: dichotomous delineation categories 'excellent-good' versus 'moderate-poor'), and report odds ratios (OR) and 95 % confidence intervals (95 %CI).
RESULTS RESULTS
From 651 patients with ICH (median age 75 years, 53 % male), we included 628 with assessable CTs. Software delineation of ICH extent was 'excellent' in 189/628 (30 %), 'good' in 255/628 (41 %), 'moderate' in 127/628 (20 %), and 'poor' in 57/628 cases (9 %). The quality of software delineation of ICH was better when fewer compartments were affected (Z = 3.61-6.27; p = 0.0063). Software delineation of ICH extent was more likely to be 'excellent-good' quality when lobar alone (OR = 1.56, 95 %CI = 0.97-2.53) but 'moderate-poor' with any intraventricular (OR = 0.56, 95 %CI = 0.39-0.81, p = 0.002) or any extra-axial (OR = 0.41, 95 %CI = 0.27-0.62, p<0.001) extension.
CONCLUSIONS CONCLUSIONS
Delineation of ICH extent on stroke CT scans by AI software was excellent or good in 71 % of cases but was more likely to over- or under-estimate extent when ICH was either more extensive, intraventricular, or extra-axial.

Identifiants

pubmed: 38007987
pii: S1052-3057(23)00533-5
doi: 10.1016/j.jstrokecerebrovasdis.2023.107512
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107512

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest GM: Consultancy fees from Canon Medical for stroke imaging software development. KWM: Institution has research agreement with Brainomix. PMB is Stroke Association Professor of Stroke Medicine and an emeritus NIHR Senior Investigator. PMW has no relevant disclosures. He reports institutional educational grants from Medtronic, Stryker and Penumbra in the last 3 years.

Auteurs

Adam Vacek (A)

Centre for Clinical Brain Sciences & UK Dementia Research Institute Centre, University of Edinburgh, UK.

Grant Mair (G)

Centre for Clinical Brain Sciences & UK Dementia Research Institute Centre, University of Edinburgh, UK. Electronic address: grant.mair@ed.ac.uk.

Philip White (P)

Translational and Clinical Research Institute, Newcastle University, UK.

Philip M Bath (PM)

Stroke Trials Unit, Mental Health & Clinical Neuroscience, University of Nottingham, UK.

Keith W Muir (KW)

School of Psychology & Neuroscience, University of Glasgow, UK.

Rustam Al-Shahi Salman (R)

Centre for Clinical Brain Sciences & UK Dementia Research Institute Centre, University of Edinburgh, UK.

Chloe Martin (C)

Centre for Clinical Brain Sciences & UK Dementia Research Institute Centre, University of Edinburgh, UK.

David Dye (D)

Centre for Clinical Brain Sciences & UK Dementia Research Institute Centre, University of Edinburgh, UK.

Francesca M Chappell (FM)

Centre for Clinical Brain Sciences & UK Dementia Research Institute Centre, University of Edinburgh, UK.

Rüdiger von Kummer (R)

Department of Neuroradiology, University Hospital, Technische Universität Dresden, Germany.

Malcolm Macleod (M)

Centre for Clinical Brain Sciences & UK Dementia Research Institute Centre, University of Edinburgh, UK.

Nikola Sprigg (N)

Stroke Trials Unit, Mental Health & Clinical Neuroscience, University of Nottingham, UK.

Joanna M Wardlaw (JM)

Centre for Clinical Brain Sciences & UK Dementia Research Institute Centre, University of Edinburgh, UK.

Classifications MeSH